Immune response to tumor cell

pathway activity — cross-omics
GO:0002418Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Immune response to tumor cell pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are DOK3, HAVCR2, and RTN4RL1, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Immune response to tumor cell activity versus DOK3 in LSCC (Pearson r = 0.16).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCDOK3 →+0.472+0.190.001.00335
GBMHAVCR2 →+0.933+0.162<.001<.00135
CCRCCRTN4RL1 →-0.816-0.432.005.00235
LSCCIL2RB →+0.752+0.263<.001<.00135
LSCCIRF1 →+0.747+0.273<.001<.00135
GBMTRPM2 →+0.632+0.137.003<.00134
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002418 vs DOK3 — LSCC

Per-sample scatter of Immune response to tumor cell activity vs DOK3 in LSCC.

Explore this scatter interactively →

Exploration